Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Swartling FJ"'
Autor:
Roberto Fattorusso, Sara Gargiulo, Francesco Salvatore, Donatella Diana, Iolanda Boffa, Matteo Gramanzini, Antonella Virgilio, Maria Elena Errico, William A. Weiss, Aldo Galeone, Louis Chesler, Valeria D'Argenio, Valentina Del Monaco, Angela Mastronuzzi, Livia Garzia, Iolanda Scognamiglio, Felice Tirone, Pasqualino De Antonellis, Emilia Pedone, Daniel Picard, Arturo Brunetti, Marianeve Carotenuto, Michael D. Taylor, Olivier Delattre, Laura Danielson, Antonio Verrico, Fatemeh Asadzadeh, Marc Remke, Fredrik J. Swartling, Donatella Montanaro, Luigi Navas, Craig Daniels, Veronica Ferrucci, Lucia Quaglietta, Ida Pisano, Massimo Zollo, Lucia Liguori, Felice Giangaspero, Francesco Paolo Pennino, Giuseppe Cinalli, Vittoria Donofrio
Publikováno v:
Brain
141 (2018): 1300–1319. doi:10.1093/brain/awy039
info:cnr-pdr/source/autori:Ferrucci V.; De Antonellis P.; Pennino F.P.; Asadzadeh F.; Virgilio A.; Montanaro D.; Galeone A.; Boffa I.; Pisano I.; Scognamiglio I.; Navas L.; DIana D.; Pedone E.; Gargiulo S.; Gramanzini M.; Brunetti A.; Danielson L.; Carotenuto M.; Liguori L.; Verrico A.; Quaglietta L.; Errico M.E.; Del Monaco V.; D'Argenio V.; Tirone F.; Mastronuzzi A.; Donofrio V.; Giangaspero F.; Picard D.; Remke M.; Garzia L.; Daniels C.; Delattre O.; Swartling F.J.; Weiss W.A.; Salvatore F.; Fattorusso R.; Chesler L.; Taylor M.D.; Cinalli G.; Zollo M./titolo:Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-?-OTX2-SNAIL via PTEN inhibition/doi:10.1093%2Fbrain%2Fawy039/rivista:Brain (Print)/anno:2018/pagina_da:1300/pagina_a:1319/intervallo_pagine:1300–1319/volume:141
141 (2018): 1300–1319. doi:10.1093/brain/awy039
info:cnr-pdr/source/autori:Ferrucci V.; De Antonellis P.; Pennino F.P.; Asadzadeh F.; Virgilio A.; Montanaro D.; Galeone A.; Boffa I.; Pisano I.; Scognamiglio I.; Navas L.; DIana D.; Pedone E.; Gargiulo S.; Gramanzini M.; Brunetti A.; Danielson L.; Carotenuto M.; Liguori L.; Verrico A.; Quaglietta L.; Errico M.E.; Del Monaco V.; D'Argenio V.; Tirone F.; Mastronuzzi A.; Donofrio V.; Giangaspero F.; Picard D.; Remke M.; Garzia L.; Daniels C.; Delattre O.; Swartling F.J.; Weiss W.A.; Salvatore F.; Fattorusso R.; Chesler L.; Taylor M.D.; Cinalli G.; Zollo M./titolo:Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-?-OTX2-SNAIL via PTEN inhibition/doi:10.1093%2Fbrain%2Fawy039/rivista:Brain (Print)/anno:2018/pagina_da:1300/pagina_a:1319/intervallo_pagine:1300–1319/volume:141
Genetic modifications during development of paediatric groups 3 and 4 medulloblastoma are responsible for their highly metastatic properties and poor patient survival rates. PRUNE1 is highly expressed in metastatic medulloblastoma group 3, which is c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58bdae99c86b253e90e615f2817931b5
https://pubmed.ncbi.nlm.nih.gov/29490009
https://pubmed.ncbi.nlm.nih.gov/29490009
Autor:
van Bree N; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden., Oppelt AS; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden., Lindström S; Comparative Medicine, Karolinska Institutet, 171 65 Stockholm, Sweden., Zhou L; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden., Boutin L; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden., Coyle B; Children's Brain Tumour Research Centre, School of Medicine, Biodiscovery Institute, University Park, University of Nottingham, Nottingham NG7 2RD, UK., Swartling FJ; Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden., Johnsen JI; Department of Women's and Children's Health, Karolinska Institutet, 171 65 Stockholm, Sweden., Bräutigam L; Comparative Medicine, Karolinska Institutet, 171 65 Stockholm, Sweden., Wilhelm M; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2024 Oct 09. Date of Electronic Publication: 2024 Oct 09.
Autor:
Holmberg KO; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, 75185 Uppsala, Sweden., Borgenvik A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Harvard Medical School, Boston, MA 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Zhao M; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, 75185 Uppsala, Sweden., Giraud G; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, 75185 Uppsala, Sweden.; Department of Women and Child Health, Uppsala University, 75124 Uppsala, Sweden.; Department of Pediatric Hematology and Oncology, Uppsala University Children's Hospital, 75185 Uppsala, Sweden., Swartling FJ; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, 75185 Uppsala, Sweden.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Apr 30; Vol. 16 (9). Date of Electronic Publication: 2024 Apr 30.
Autor:
Lu X; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Zhong L; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.; Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, Sichuan, China., Lindell E; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Veanes M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Guo J; Centre for Computational Biology, Duke-NUS Medical School, 8 College Road, 169857, Singapore, Singapore., Zhao M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Salehi M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Swartling FJ; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Chen X; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Sjöblom T; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Zhang X; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. Xiaonan.zhang@igp.uu.se.
Publikováno v:
Cell death & disease [Cell Death Dis] 2023 Oct 13; Vol. 14 (10), pp. 676. Date of Electronic Publication: 2023 Oct 13.
Autor:
Doloczki S; Department of Chemistry - BMC, Uppsala University, Box 576, 75123, Uppsala, Sweden., Kern C; Department of Chemistry - BMC, Uppsala University, Box 576, 75123, Uppsala, Sweden., Holmberg KO; Department of Immunology, Genetics and Pathology, Uppsala University, Rudbeck Laboratory, 75185, Uppsala, Sweden., Swartling FJ; Department of Immunology, Genetics and Pathology, Uppsala University, Rudbeck Laboratory, 75185, Uppsala, Sweden., Streuff J; Department of Chemistry - BMC, Uppsala University, Box 576, 75123, Uppsala, Sweden., Dyrager C; Department of Chemistry - BMC, Uppsala University, Box 576, 75123, Uppsala, Sweden.
Publikováno v:
Chemistry (Weinheim an der Bergstrasse, Germany) [Chemistry] 2023 Sep 12; Vol. 29 (51), pp. e202300864. Date of Electronic Publication: 2023 Aug 09.
Autor:
Mainwaring OJ; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Weishaupt H; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Zhao M; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Rosén G; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Borgenvik A; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Breinschmid L; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Verbaan AD; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Richardson S; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle upon Tyne, NE1 7RU, UK., Thompson D; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle upon Tyne, NE1 7RU, UK., Clifford SC; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle upon Tyne, NE1 7RU, UK., Hill RM; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle upon Tyne, NE1 7RU, UK., Annusver K; Department of Cell and Molecular Biology, Karolinska Institutet, 171 77, Stockholm, Sweden., Sundström A; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Holmberg KO; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Kasper M; Department of Cell and Molecular Biology, Karolinska Institutet, 171 77, Stockholm, Sweden., Hutter S; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Swartling FJ; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden. fredrik.swartling@igp.uu.se.
Publikováno v:
Nature communications [Nat Commun] 2023 Mar 03; Vol. 14 (1), pp. 1221. Date of Electronic Publication: 2023 Mar 03.
Autor:
Weishaupt H; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Čančer M; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Rosén G; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Holmberg KO; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Häggqvist S; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Bunikis I; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Jiang Y; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Sreedharan S; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Gyllensten U; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Becher OJ; Department of Pediatrics and Biochemistry and Molecular Genetics, Northwestern University, Chicago, Illinois, USA.; Department of Pediatrics and Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Uhrbom L; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Ameur A; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Swartling FJ; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2023 Jan 05; Vol. 25 (1), pp. 97-107.
Autor:
Borgenvik A; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Holmberg KO; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Bolin S; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Zhao M; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Savov V; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Rosén G; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Hutter S; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Garancher A; Tumor Initiation & Maintenance Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, San Diego, California., Rahmanto AS; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden., Bergström T; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Olsen TK; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Mainwaring OJ; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Sattanino D; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Verbaan AD; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Rusert JM; Tumor Initiation & Maintenance Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, San Diego, California., Sundström A; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Bravo MB; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Dang Y; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Biomedical Centre, Uppsala University, Uppsala, Sweden., Wenz AS; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Biomedical Centre, Uppsala University, Uppsala, Sweden., Richardson S; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle upon Tyne, United Kingdom., Fotaki G; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Hill RM; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle upon Tyne, United Kingdom., Dubuc AM; The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada., Kalushkova A; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Remke M; The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada., Čančer M; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Jernberg-Wiklund H; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Giraud G; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Chen X; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Biomedical Centre, Uppsala University, Uppsala, Sweden., Taylor MD; The Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada., Sangfelt O; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden., Clifford SC; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle upon Tyne, United Kingdom., Schüller U; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department of Paediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany., Wechsler-Reya RJ; Tumor Initiation & Maintenance Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, San Diego, California., Weishaupt H; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden., Swartling FJ; Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
Publikováno v:
Cancer research [Cancer Res] 2022 Dec 16; Vol. 82 (24), pp. 4586-4603.
Autor:
Jakobsson AW; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85 Uppsala, Sweden., Kundu S; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85 Uppsala, Sweden., Guo J; Centre for Computational Biology, Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore., Chowdhury A; Department of Medical Cell Biology, Uppsala University, BMC, Husargatan 3, SE-75123 Uppsala, Sweden., Zhao M; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85 Uppsala, Sweden., Lindell E; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85 Uppsala, Sweden., Bergsten P; Department of Medical Cell Biology, Uppsala University, BMC, Husargatan 3, SE-75123 Uppsala, Sweden., Swartling FJ; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85 Uppsala, Sweden., Sjöblom T; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85 Uppsala, Sweden., Zhang X; Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85 Uppsala, Sweden.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Jun 30; Vol. 14 (13). Date of Electronic Publication: 2022 Jun 30.
Autor:
Doloczki S; Department of Chemistry - BMC, Uppsala University Box 576 75123 Uppsala Sweden christine.dyrager@kemi.uu.se., Holmberg KO; Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University 75185 Uppsala Sweden., Fdez Galván I; Department of Chemistry - BMC, Uppsala University Box 576 75123 Uppsala Sweden christine.dyrager@kemi.uu.se., Swartling FJ; Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University 75185 Uppsala Sweden., Dyrager C; Department of Chemistry - BMC, Uppsala University Box 576 75123 Uppsala Sweden christine.dyrager@kemi.uu.se.
Publikováno v:
RSC advances [RSC Adv] 2022 May 13; Vol. 12 (23), pp. 14544-14550. Date of Electronic Publication: 2022 May 13 (Print Publication: 2022).